Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
• Institutions.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Publications

Search Items: HYPOGLYCEMIC AGENTS - THERAPEUTIC USE , . hits: 86

2023

Kastner, JR; Poettler, T; Kopanz, J; Hochfellner, DA; Romey, M; Baumann, PM; Muchmore, D; Strasma, PJ; Mader, JK Current insulin infusion set failure criteria may be too stringent for real-life settings and may skew infusion set failure outcomes in extended-wear infusion set studies.
Diabetes Obes Metab. 2023; 25(4):1106-1111 Doi: 10.1111/dom.14935
Web of Science PubMed FullText FullText_MUG

 

Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Aziz, F; Müller, A; Schauer, M; Oulhaj, A; Aberer, F; Sourij, C; Habisch, H; Madl, T; Pieber, T; Obermayer-Pietsch, B; Stadlbauer, V; Sourij, H Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled Trial.
Diabetes Care. 2023; 46(2):463-468 Doi: 10.2337/dc22-1622 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, SE; Fritsch, M [Diabetes mellitus in childhood and adolescence (Update 2023)].
Wien Klin Wochenschr. 2023; 135(Suppl 1): 106-114. Doi: 10.1007/s00508-023-02169-5 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Thabit, H; Boughton, C; Mubita, W; Rubio, J; Mader, JK; Narendran, P; Evans, M; Leelarathna, L; Wilinska, ME; Fullwood, C; Gregory, AM; Hovorka, R; Rutter, MK Impact of the CamAPS FX hybrid closed-loop insulin delivery system on sleep traits in older adults with type 1 diabetes.
Diabetes Obes Metab. 2023; 25(3):889-893 Doi: 10.1111/dom.14914 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2022

Divilly, P; Zaremba, N; Mahmoudi, Z; Søholm, U; Pollard, DJ; Broadley, M; Abbink, EJ; de, Galan, B; Pedersen-Bjergaard, U; Renard, E; Evans, M; Speight, J; Brennan, A; McCrimmon, RJ; Müllenborn, M; Heller, S; Seibold, A; Mader, JK; Amiel, SA; Pouwer, F; Choudhary, P, , Hypo-RESOLVE, Consortium Hypo-METRICS: Hypoglycaemia-MEasurement, ThResholds and ImpaCtS-A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: The study protocol.
Diabet Med. 2022; 39(9):e14892 Doi: 10.1111/dme.14892 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Jacan, A; Schauer, M; Aziz, F; Oulhaj, A; Aberer, F; Sourij, C; Obermayer-Pietsch, B; Stadlbauer, V; Sourij, H INTERmittent FASTing in people with insulin-treated type 2 diabetes mellitus - the INTERFAST-2 study protocol.
Diabet Med. 2022; 39(6):e14813 Doi: 10.1111/dme.14813 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schütz, AK; Schütz-Fuhrmann, I; Stadler, M; Staudinger, H; Mader, JK Management of Type 1 Diabetes Mellitus Using Open-Source Automated Insulin Delivery During Pregnancy: A Case Series.
Diabetes Technol Ther. 2022; 24(3):227-230 Doi: 10.1089/dia.2021.0260
Web of Science PubMed FullText FullText_MUG

 

2021

Boughton, CK; Hartnell, S; Thabit, H; Poettler, T; Herzig, D; Wilinska, ME; Ashcroft, NL; Sibayan, J; Cohen, N; Calhoun, P; Bally, L; Mader, JK; Evans, M; Leelarathna, L; Hovorka, R Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover study.
Diabetes Obes Metab. 2021; 23(6):1389-1396 Doi: 10.1111/dom.14355
Web of Science PubMed FullText FullText_MUG

 

Hecking, M; Sharif, A; Eller, K; Jenssen, T Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics.
Transpl Int. 2021; 34(1):27-48 Doi: 10.1111/tri.13783 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schnedl, WJ; Holasek, SJ; Schenk, M; Enko, D; Mangge, H Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment.
Wien Klin Wochenschr. 2021; 133(5-6):241-244 Doi: 10.1007/s00508-020-01770-2
Web of Science PubMed FullText FullText_MUG

 

Simic, A; Schøndorff, PK; Stumpe, T; Heschel, M; Regittnig, W; Pöttler, T; Ninaus, D; Augustin, T; Groselj-Strele, A; Pieber, TR; Mader, JK, ;on behalf of the Hypo-RESOLVE, Consortium;AiDAPT, AP@home04, CLOuD, DAN05, DAN06, and, KidsAP, consortia;HYPO-RESOLVE, Consortium;KidsAP, Consortium Survival assessment of the extended-wear insulin infusion set featuring lantern technology in adults with type 1 diabetes by the glucose clamp technique.
Diabetes Obes Metab. 2021; 23(6):1402-1408 Doi: 10.1111/dom.14337 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Tarride, JE; Husain, M; Andersen, A; Gundgaard, J; Luckevich, M; Mark, T; Wagner, L; Pieber, TR Hospitalization costs with degludec versus glargine U100 for patients with type 2 diabetes at high cardiovascular risk: Canadian costs applied to SAEs from a randomized outcomes trial.
J Med Econ. 2021; 24(1): 1318-1326. Doi: 10.1080/13696998.2021.2003804
Web of Science PubMed FullText FullText_MUG

 

2020

Tschaikner, M; Simic, A; Jungklaus, M; Fritz, M; Ellmerer, M; Pieber, TR; Regittnig, W Development of a Single-Site Device for Conjoined Glucose Sensing and Insulin Delivery in Type-1 Diabetes Patients.
IEEE Trans Biomed Eng. 2020; 67(1):312-322 Doi: 10.1109/TBME.2019.2919234
Web of Science PubMed FullText FullText_MUG

 

2019

Clodi, M; Abrahamian, H; Brath, H; Brix, J; Drexel, H; Fasching, P; Föger, B; Francesconi, C; Fröhlich-Reiterer, E; Harreiter, J; Hofer, SE; Hoppichler, F; Huber, J; Kaser, S; Kautzky-Willer, A; Lechleitner, M; Ludvik, B; Luger, A; Mader, JK; Paulweber, B; Pieber, T; Prager, R; Rami-Merhar, B; Resl, M; Riedl, M; Roden, M; Saely, CH; Schelkshorn, C; Schernthaner, G; Sourij, H; Stechemesser, L; Stingl, H; Toplak, H; Wascher, TC; Weitgasser, R; Winhofer-Stöckl, Y; Zlamal-Fortunat, S [Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):27-38 Doi: 10.1007/s00508-019-1471-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lechleitner, M; Clodi, M; Abrahamian, H; Brath, H; Brix, J; Drexel, H; Fasching, P; Föger, B; Francesconi, C; Fröhlich-Reiterer, E; Harreiter, J; Hofer, SE; Hoppichler, F; Huber, J; Kaser, S; Kautzky-Willer, A; Ludvik, B; Luger, A; Mader, JK; Paulweber, B; Pieber, T; Prager, R; Rami-Merhar, B; Resl, M; Riedl, M; Roden, M; Saely, CH; Schelkshorn, C; Schernthaner, G; Sourij, H; Stechemesser, L; Stingl, H; Toplak, H; Wascher, TC; Weitgasser, R; Winhofer-Stöckl, Y; Zlamal-Fortunat, S [Insulin therapy of type 2 diabetes mellitus (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):39-46 Doi: 10.1007/s00508-019-1492-7
Web of Science PubMed FullText FullText_MUG

 

Moser, O; Pandis, M; Aberer, F; Kojzar, H; Hochfellner, D; Elsayed, H; Motschnig, M; Augustin, T; Kreuzer, P; Pieber, TR; Sourij, H; Mader, JK A head-to-head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: Hypoglycaemia remains the weak spot.
Diabetes Obes Metab. 2019; 21(4):1043-1048 Doi: 10.1111/dom.13598 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pratley, RE; Husain, M; Lingvay, I; Pieber, TR; Mark, T; Saevereid, HA; Møller, DV; Zinman, B; DEVOTE Study Group Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14.
Cardiovasc Diabetol. 2019; 18(1):156-156 Doi: 10.1186/s12933-019-0960-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, SE [Diabetes mellitus in childhood and adolescence (Update 2019)].
WIEN KLIN WOCHENSCHR. 2019; 131(Suppl 1): 85-90. Doi: 10.1007/s00508-018-1420-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schütz-Fuhrmann, I; Stadler, M; Zlamal-Fortunat, S; Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, SE; Mader, J; Resl, M; Bischof, M; Kautzky-Willer, A; Weitgasser, R [Insulin pump therapy in children, adolescents and adults, guidelines (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):47-53 Doi: 10.1007/s00508-019-1485-6
Web of Science PubMed FullText FullText_MUG

 

2018

de Sousa, G; Prinz, N; Becker, M; Dürr, R; Faller, U; Meraner, D; Heise, N; Engelmann, I; Bruckmayer, H; Wiemann, D; Fritsch, M; Stratmann, B; Holl, RW Diabetes Mellitus and Autoimmune Hepatitis: Demographical and Clinical Description of a Relatively Rare Phenotype.
Horm Metab Res. 2018; 50(7): 568-574. Doi: 10.1055/a-0631-2468 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pieber, TR; Marso, SP; McGuire, DK; Zinman, B; Poulter, NR; Emerson, SS; Pratley, RE; Woo, V; Heller, S; Lange, M; Brown-Frandsen, K; Moses, A; Barner Lekdorf, J; Lehmann, L; Kvist, K; Buse, JB; DEVOTE Study Group DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality.
Diabetologia. 2018; 61(1):58-65 Doi: 10.1007/s00125-017-4422-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zinman, B; Marso, SP; Poulter, NR; Emerson, SS; Pieber, TR; Pratley, RE; Lange, M; Brown-Frandsen, K; Moses, A; Ocampo Francisco, AM; Barner Lekdorf, J; Kvist, K; Buse, JB; DEVOTE Study Group Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).
Diabetologia. 2018; 61(1):48-57 Doi: 10.1007/s00125-017-4423-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Bally, L; Thabit, H; Kojzar, H; Mader, JK; Qerimi-Hyseni, J; Hartnell, S; Tauschmann, M; Allen, JM; Wilinska, ME; Pieber, TR; Evans, ML; Hovorka, R Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study.
Lancet Diabetes Endocrinol. 2017; 5(4):261-270 Doi: 10.1016/S2213-8587(17)30001-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Emami, A; Willinska, ME; Thabit, H; Leelarathna, L; Hartnell, S; Dellweg, S; Benesch, C; Mader, JK; Holzer, M; Kojzar, H; Pieber, TR; Arnolds, S; Evans, ML; Hovorka, R Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
Diabetes Technol Ther. 2017; 19(7):433-437 Doi: 10.1089/dia.2016.0307 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Famulla, S; Pieber, TR; Eilbracht, J; Neubacher, D; Soleymanlou, N; Woerle, HJ; Broedl, UC; Kaspers, S Glucose Exposure and Variability with Empagliflozin as Adjunct to Insulin in Patients with Type 1 Diabetes: Continuous Glucose Monitoring Data from a 4-Week, Randomized, Placebo-Controlled Trial (EASE-1).
Diabetes Technol Ther. 2017; 19(1):49-60 Doi: 10.1089/dia.2016.0261
Web of Science PubMed FullText FullText_MUG

 

Ioacara, S; Flanagan, S; Fröhlich-Reiterer, E; Goland, R; Fica, S First case of neonatal diabetes with KCNJ11 Q52R mutation successfully switched from insulin to sulphonylurea treatment.
J Diabetes Investig. 2017; 8(5):716-719 Doi: 10.1111/jdi.12620 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Marso, SP; McGuire, DK; Zinman, B; Poulter, NR; Emerson, SS; Pieber, TR; Pratley, RE; Haahr, PM; Lange, M; Brown-Frandsen, K; Moses, A; Skibsted, S; Kvist, K; Buse, JB; DEVOTE Study Group Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
N Engl J Med. 2017; 377(8):723-732 Doi: 10.1056/NEJMoa1615692 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Moser, O; Tschakert, G; Mueller, A; Groeschl, W; Pieber, TR; Koehler, G; Eckstein, ML; Bracken, RM; Hofmann, P Atypical blood glucose response to continuous and interval exercise in a person with type 1 diabetes: a case report.
J Med Case Rep. 2017; 11(1):176-176 Doi: 10.1186/s13256-017-1355-7 (- Case Report) [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Tiffner, K; Boulgaropoulos, B; Höfferer, C; Birngruber, T; Porksen, N; Linnebjerg, H; Garhyan, P; Lam, ECQ; Knadler, MP; Pieber, TR; Sinner, F Quantification of Basal Insulin Peglispro and Human Insulin in Adipose Tissue Interstitial Fluid by Open-Flow Microperfusion.
Diabetes Technol Ther. 2017; 19(5):305-314 Doi: 10.1089/dia.2016.0384
Web of Science PubMed FullText FullText_MUG

 

von Lewinski, D; Kolesnik, E; Wallner, M; Resl, M; Sourij, H New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data.
Biomed Res Int. 2017; 2017(9):1253425-1253425 Doi: 10.1155/2017/1253425 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Cimenti, C; Schlagenhauf, A; Leschnik, B; Fröhlich-Reiterer, E; Jasser-Nitsche, H; Haidl, H; Suppan, E; Weinhandl, G; Leberl, M; Borkenstein, M; Muntean, WE Only minor changes in thrombin generation of children and adolescents with type 1 diabetes mellitus - A case-control study.
Thromb Res. 2016; 148(8):45-49 Doi: 10.1016/j.thromres.2016.10.016
Web of Science PubMed FullText FullText_MUG

 

Ferrannini, E; Baldi, S; Frascerra, S; Astiarraga, B; Heise, T; Bizzotto, R; Mari, A; Pieber, TR; Muscelli, E Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes.
Diabetes. 2016; 65(5):1190-1195 Doi: 10.2337/db15-1356 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fullerton, B; Siebenhofer, A; Jeitler, K; Horvath, K; Semlitsch, T; Berghold, A; Plank, J; Pieber, TR; Gerlach, FM Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.
Cochrane Database Syst Rev. 2016; 29(6):CD012161-CD012161 Doi: 10.1002/14651858.CD012161 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mader, JK; Jensen, L; Ingwersen, SH; Christiansen, E; Heller, S; Pieber, TR Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus.
Clin Pharmacokinet. 2016; 55(11):1457-1463 Doi: 10.1007/s40262-016-0413-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Marso, SP; McGuire, DK; Zinman, B; Poulter, NR; Emerson, SS; Pieber, TR; Pratley, RE; Haahr, PM; Lange, M; Frandsen, KB; Rabøl, R; Buse, JB Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1.
Am Heart J. 2016; 179(19-20):175-183 Doi: 10.1016/j.ahj.2016.06.004 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Moser, O; Mader, JK; Tschakert, G; Mueller, A; Groeschl, W; Pieber, TR; Koehler, G; Messerschmidt, J; Hofmann, P Accuracy of Continuous Glucose Monitoring (CGM) during Continuous and High-Intensity Interval Exercise in Patients with Type 1 Diabetes Mellitus.
Nutrients. 2016; 8(8): Doi: 10.3390/nu8080489 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Riedl, R; Robausch, M; Berghold, A The Evaluation of the Effectiveness of Austrians Disease Management Program in Patients with Type 2 Diabetes Mellitus - A Population-Based Retrospective Cohort Study.
PLoS One. 2016; 11(8):e0161429-e0161429 Doi: 10.1371/journal.pone.0161429 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zannad, F; Stough, WG; Lipicky, RJ; Tamargo, J; Bakris, GL; Borer, JS; Alonso García, Mde L; Hadjadj, S; Koenig, W; Kupfer, S; McCullough, PA; Mosenzon, O; Pocock, S; Scheen, AJ; Sourij, H; Van der Schueren, B; Stahre, C; White, WB; Calvo, G Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion.
Eur Heart J Cardiovasc Pharmacother. 2016; 2(3):200-205 Doi: 10.1093/ehjcvp/pvw007 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Brunner, M; Pieber, T; Korsatko, S; Kojzar, H; Svendsen, AL; Haahr, H The Distinct Prandial and Basal Pharmacodynamics of IDegAsp Observed in Younger Adults Are Preserved in Elderly Subjects with Type 1 Diabetes.
Drugs Aging. 2015; 32(7):583-590 Doi: 10.1007/s40266-015-0272-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hermanns, N; Lilly, LC; Mader, JK; Aberer, F; Ribitsch, A; Kojzar, H; Warner, J; Pieber, TR Novel simple insulin delivery device reduces barriers to insulin therapy in type 2 diabetes: results from a pilot study.
J Diabetes Sci Technol. 2015; 9(3):581-587 Doi: 10.1177/1932296815570709 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Kropff, J; Bruttomesso, D; Doll, W; Farret, A; Galasso, S; Luijf, YM; Mader, JK; Place, J; Boscari, F; Pieber, TR; Renard, E; DeVries, JH Accuracy of two continuous glucose monitoring systems: a head-to-head comparison under clinical research centre and daily life conditions.
Diabetes Obes Metab. 2015; 17(4):343-349 Doi: 10.1111/dom.12378 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

McKnight, JA; Wild, SH; Lamb, MJ; Cooper, MN; Jones, TW; Davis, EA; Hofer, S; Fritsch, M; Schober, E; Svensson, J; Almdal, T; Young, R; Warner, JT; Delemer, B; Souchon, PF; Holl, RW; Karges, W; Kieninger, DM; Tigas, S; Bargiota, A; Sampanis, C; Cherubini, V; Gesuita, R; Strele, I; Pildava, S; Coppell, KJ; Magee, G; Cooper, JG; Dinneen, SF; Eeg-Olofsson, K; Svensson, AM; Gudbjornsdottir, S; Veeze, H; Aanstoot, HJ; Khalangot, M; Tamborlane, WV; Miller, KM Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison.
Diabet Med. 2015; 32(8): 1036-1050. Doi: 10.1111/dme.12676
Web of Science PubMed FullText FullText_MUG

 

Muschitz, C; Thaler, HW; Dimai, HP; Resch, H; Kocijan, R; Kostic, M; Geiger, C; Kaider, A; Muschitz, GK; Szivak, M; Pietschmann, P Atypical Femoral Fractures-Ongoing and History of Bone-Specific Therapy, Concomitant Diseases, Medications, and Survival.
J Clin Densitom. 2015; 19(3):359-367 Doi: 10.1016/j.jocd.2015.05.070
Web of Science PubMed FullText FullText_MUG

 

Neubauer, KM; Mader, JK; Höll, B; Aberer, F; Donsa, K; Augustin, T; Schaupp, L; Spat, S; Beck, P; Fruhwald, FM; Schnedl, C; Rosenkranz, AR; Lumenta, DB; Kamolz, LP; Plank, J; Pieber, TR Standardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes on Different Wards.
Diabetes Technol Ther. 2015; 17(10):685-692 Doi: 10.1089/dia.2015.0027 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pieber, TR; Deller, S; Korsatko, S; Jensen, L; Christiansen, E; Madsen, J; Heller, SR Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial.
Diabetes Obes Metab. 2015; 17(8):742-750 Doi: 10.1111/dom.12473
Web of Science PubMed FullText FullText_MUG

 

Scheuing, N; Wiegand, S; Bächle, C; Fröhlich-Reiterer, E; Hahn, E; Icks, A; Ludwig, KH; Mönkemöller, K; Razum, O; Rosenbauer, J; Holl, RW; DPV initiative Impact of Maternal Country of Birth on Type-1-Diabetes Therapy and Outcome in 27,643 Children and Adolescents from the DPV Registry.
PLoS One. 2015; 10(8):e0135178-e0135178 Doi: 10.1371/journal.pone.0135178 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Amrein, K; Kachel, N; Fries, H; Hovorka, R; Pieber, TR; Plank, J; Wenger, U; Lienhardt, B; Maggiorini, M Glucose control in intensive care: usability, efficacy and safety of Space GlucoseControl in two medical European intensive care units.
BMC Endocr Disord. 2014; 14(8):62-62 Doi: 10.1186/1472-6823-14-62 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Holman, RR; Sourij, H; Califf, RM Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes.
Lancet. 2014; 383(9933):2008-2017 Doi: 10.1016/S0140-6736(14)60794-7
Web of Science PubMed FullText FullText_MUG

 

Leelarathna, L; Dellweg, S; Mader, JK; Allen, JM; Benesch, C; Doll, W; Ellmerer, M; Hartnell, S; Heinemann, L; Kojzar, H; Michalewski, L; Nodale, M; Thabit, H; Wilinska, ME; Pieber, TR; Arnolds, S; Evans, ML; Hovorka, R; AP@home Consortium Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study.
Diabetes Care. 2014; 37(7):1931-1937 Doi: 10.2337/dc13-2911 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rieken, M; Kluth, LA; Xylinas, E; Fajkovic, H; Becker, A; Karakiewicz, PI; Herman, M; Lotan, Y; Seitz, C; Schramek, P; Remzi, M; Loidl, W; Pummer, K; Lee, RK; Faison, T; Scherr, DS; Kautzky-Willer, A; Bachmann, A; Tewari, A; Shariat, SF Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer.
World J Urol. 2014; 32(4):999-1005 Doi: 10.1007/s00345-013-1171-7
Web of Science PubMed FullText FullText_MUG

 

Show the next 50 results of search

↑ Top of page / Navigation

© Med Uni Graz • Imprint